# Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia

> **NCT03374709** · PHASE4 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Trigeminal Neuralgia

## Interventions

- **DRUG:** Oxtellar XR 150Mg Extended Release Tablet

## Key facts

- **NCT ID:** NCT03374709
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12-14
- **Primary completion:** 2018-12-14
- **Final completion:** 2018-12-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Resource and time constraints were encountered by product manufacturer and study team.
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03374709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03374709, "Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03374709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*